New Amsterdam Pharma
About:
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
Website: https://www.newamsterdampharma.com
Top Investors: RA Capital Management, Forbion Capital Partners, Bain Capital Life Sciences, Frazier Healthcare Partners, Kaiser Permanente
Description:
NewAmsterdam Pharma is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
Total Funding Amount:
$786M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Naarden, Noord-Holland, The Netherlands
Founded Date:
2019-01-01
Founders:
John J.P. Kastelein
Number of Employees:
11-50
Last Funding Date:
2024-02-13
IPO Status:
Public
© 2025 bioDAO.ai